|
1
|
Cai Y, Yan X, Zhang G, Zhao W and Jiao S:
MicroRNA-205 increases the sensitivity of docetaxel in breast
cancer. Oncol Lett. 11:1105–1109. 2016.PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiao X, Huang X, Ye F, Chen B, Song C, Wen
J, Zhang Z, Zheng G, Tang H and Xie X: The miR-34a-LDHA axis
regulates glucose metabolism and tumor growth in breast cancer. Sci
Rep. 6:217352016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cardoso F, Harbeck N, Fallowfield L,
Kyriakides S and Senkus E; ESMO Guidelines Working Group, : Locally
recurrent or metastatic breast cancer: ESMO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol. 23
Suppl 7:vii11–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y and Blelloch R: Cell cycle
regulation by MicroRNAs in embryonic stem cells. Cancer Res.
69:4093–4096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van Kouwenhove M, Kedde M and Agami R:
MicroRNA regulation by RNA-binding proteins and its implications
for cancer. Nat Rev Cancer. 11:644–656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang T, Hu Y, Ju J, Hou L, Li Z, Xiao D,
Li Y, Yao J, Wang C, Zhang Y, et al: Downregulation of miR-522
suppresses proliferation and metastasis of non-small cell lung
cancer cells by directly targeting DENN/MADD domain containing 2D.
Sci Rep. 6:193462016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Lu G, Ke X, Lu X, Wang X, Li H,
Ren M and He S: miR-488 acts as a tumor suppressor gene in gastric
cancer. Tumour Biol. 37:8691–8698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang L, Song G, Tan W, Qi M, Zhang L, Chan
J, Yu J, Han J and Han B: MiR-573 inhibits prostate cancer
metastasis by regulating epithelial-mesenchymal transition.
Oncotarget. 6:35978–35990. 2015.PubMed/NCBI
|
|
11
|
Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye
F and Xie X, Chen J, Tang H and Xie X: miR-200c inhibits breast
cancer proliferation by targeting KRAS. Oncotarget. 6:34968–34978.
2015.PubMed/NCBI
|
|
12
|
Wang L, Li L, Guo R, Li X, Lu Y, Guan X,
Gitau SC, Wang L, Xu C, Yang B and Shan H: miR-101 promotes breast
cancer cell apoptosis by targeting Janus kinase 2. Cell Physiol
Biochem. 34:413–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li G, Yao L, Zhang J, Li X, Dang S, Zeng
K, Zhou Y and Gao F: Tumor-suppressive microRNA-34a inhibits breast
cancer cell migration and invasion via targeting oncogenic TPD52.
Tumour Biol. 37:7481–7491. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Voorhoeve PM, le Sage C, Schrier M, Gillis
AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A,
et al: A genetic screen implicates miRNA-372 and miRNA-373 as
oncogenes in testicular germ cell tumors. Cell. 124:1169–1181.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cho WJ, Shin JM, Kim JS, Lee MR, Hong KS,
Lee JH, Koo KH, Park JW and Kim KS: miR-372 regulates cell cycle
and apoptosis of ags human gastric cancer cell line through direct
regulation of LATS2. Mol Cells. 28:521–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Hao B, Han G, Liu Y, Dai D, Li Y,
Wu X, Zhou X, Yue Z, Wang L, et al: miR-372 regulates glioma cell
proliferation and invasion by directly targeting PHLPP2. J Cell
Biochem. 116:225–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang X, Huang M, Kong L and Li Y: miR-372
suppresses tumour proliferation and invasion by targeting IGF2BP1
in renal cell carcinoma. Cell Prolif. 48:593–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu BL, Sun KX, Zong ZH, Chen S and Zhao
Y: MicroRNA-372 inhibits endometrial carcinoma development by
targeting the expression of the Ras homolog gene family member C
(RhoC). Oncotarget. 7:6649–6664. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fu SW, Lee W, Coffey C, Lean A, Wu X, Tan
X, Man YG and Brem RF: miRNAs as potential biomarkers in early
breast cancer detection following mammography. Cell Biosci.
6:62016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inoue K and Fry EA: Novel molecular
markers for breast cancer. Biomark Cancer. 8:25–42. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takahashi RU, Miyazaki H and Ochiya T: The
Roles of microRNAs in breast cancer. Cancers (Basel). 7:598–616.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mulrane L, Klinger R, McGee SF, Gallagher
WM and O'Connor DP: microRNAs: A new class of breast cancer
biomarkers. Expert Rev Mol Diagn. 14:347–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhan L, Zhang Y, Wang W, Song E, Fan Y and
Wei B: E2F1: A promising regulator in ovarian carcinoma. Tumour
Biol. 37:2823–2831. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
DeGregori J and Johnson DG: Distinct and
overlapping roles for E2F family members in transcription,
proliferation and apoptosis. Curr Mol Med. 6:739–748. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Knoll S, Emmrich S and Pützer BM: The
E2F1-miRNA cancer progression network. Adv Exp Med Biol.
774:135–147. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang G, Zhang R, Chen X, Mu Y, Ai J, Shi
C, Liu Y, Shi C, Sun L, Rainov NG, et al: MiR-106a inhibits glioma
cell growth by targeting E2F1 independent of p53 status. J Mol Med
(Berl). 89:1037–1050. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dar AA, Majid S, de Semir D, Nosrati M,
Bezrookove V and Kashani-Sabet M: miRNA-205 suppresses melanoma
cell proliferation and induces senescence via regulation of E2F1
protein. J Biol Chem. 286:16606–16614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiao B, Tan L, He B, Liu Z and Xu R:
MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma
cells. J Transl Med. 11:1722013. View Article : Google Scholar : PubMed/NCBI
|
